Healthcare · head to head
Lunit vs Tebra

Lunit
Healthcare
FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography
- From
- On request
- Rated
- -

Tebra
Healthcare
Practice management combining EHR, billing and patient engagement for independent practices
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Tebra no pricing amounts published; custom quote required based on practice configuration
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Lunit and Tebra actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), platforms (Web), user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Lunit
- Lunit INSIGHT MMG
- Lunit INSIGHT DBT
- Lunit INSIGHT CXR
- Volpara density assessment
- Volpara RiskPathways
- Volpara dose tracking
- PACS and mammography workstation integration
Only in Tebra
Nothing recorded that Lunit does not also cover.
What people use each for
The jobs each tool is most often brought in to do.
Lunit
- A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Tebra
- A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Tebra
- An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Tebra
- A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Tebra
Tebra
- Consolidating scheduling, charting, billing into single systemnot Lunit
- Automating claims submission and denial managementnot Lunit
- Reducing appointment no-shows through automated remindersnot Lunit
- Reducing documentation time to five minutes with AInot Lunit
- E-prescribing controlled substances with PDMP and EPCSnot Lunit
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Lunit
- The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
- Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
- Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
- MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
- Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.
Tebra
- No pricing amounts published; custom quote required based on practice configuration
- Pricing based on per-provider licensing model with additional costs for EPCS setup and PDMP integration
Pricing, plan by plan
Lunit
On request- Lunit INSIGHT$undefined/year
- Priced per study or per annual examination volume by product
- MMG, DBT and CXR licensed separately
- Volpara density and RiskPathways modules quoted separately
Tebra
On requestNo published plan breakdown. See the Tebra review.
Which should you pick?
Choose Tebra if
Nothing in the data separates Tebra from Lunit on the points above - pick on price and on how each one feels to use.
Questions people ask
- Is Lunit or Tebra better?
- Neither clearly leads. Lunit starts at On request and Tebra at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Lunit or Tebra?
- Lunit starts at On request and Tebra at On request.
- Does Lunit or Tebra run on more platforms?
- Both run on Web, so platform support will not decide this one for you.
- What is Lunit best used for?
- Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Tebra is typically brought in for.
- What can Lunit do that Tebra cannot?
- Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.
Answered from the vendors’ own pages
Lunit: Is Lunit FDA cleared?
Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.
Tebra: How does Tebra's pricing model work?
Pricing is based on the number of clinical providers rather than user seats. Non-clinical staff get unlimited access at no additional cost. Low-volume providers billing under 100 claims monthly receive lower-tier pricing.
SourceLunit: Can Lunit replace a second human reader in screening?
That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.
Tebra: What are the setup and integration costs beyond the monthly fee?
Electronic Prescribing Controlled Substances (EPCS) setup costs approximately $75 per provider as a one-time fee. PDMP integration costs $500 one-time per facility plus approximately $50 per user per year.
SourceLunit: What did the Volpara acquisition add?
Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.
Tebra: Are there volume discounts for practices using multiple modules?
Yes, bundled pricing and volume incentives are available for multi-module adoption. Practices can request a personalized quote to see potential savings.
SourceLunit: Is pricing published?
No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.
Tebra: Does Tebra offer published pricing or is a quote always required?
Tebra does not publish specific monthly costs. Pricing varies depending on the number of providers, platform features needed, and implementation requirements. A personalized quote is required to get pricing.
SourceRelated pages
Other head to heads
- Lunit vs Therapixel
- Lunit vs Aidoc
- Lunit vs Techcyte
- Lunit vs Gleamer
- Lunit vs PathAI
- Lunit vs Paige
- Lunit vs Ibex Medical Analytics
- Lunit vs Philips IntelliSpace PACS
- Lunit vs Annalise.ai
- Lunit vs Sysmex
- Lunit vs Sectra
- Lunit vs Lyra Health
- Lunit vs Visage Imaging
- Lunit vs WebPT
- Lunit vs Allscripts
- Lunit vs Clue
- Lunit vs Dentrix
- Lunit vs DHIS2
- Lunit vs Athenahealth
- Lunit vs Epic Systems
- Lunit vs Cerner
- Lunit vs Amwell
- Lunit vs ChiroTouch
- Lunit vs RXNT
- Lunit vs Updox
- Lunit vs Kareo
- Lunit vs Healthie
- Lunit vs Allscripts Professional EHR
- Lunit vs Bahmni
- Lunit vs Beckman Coulter DxONE
- Lunit vs Carestream Dental
- Lunit vs athenaOne
- Lunit vs Kareo Clinical
- Lunit vs Allscripts TouchWorks
- Tebra vs Therapixel
- Tebra vs Aidoc
- Tebra vs Techcyte
- Tebra vs Gleamer
- Tebra vs PathAI
- Tebra vs Paige
- Tebra vs Ibex Medical Analytics
- Tebra vs Philips IntelliSpace PACS
- Tebra vs Annalise.ai
- Tebra vs Sysmex
- Tebra vs Sectra
- Tebra vs Lyra Health
- Tebra vs Visage Imaging
- Tebra vs WebPT
- Tebra vs Allscripts
- Tebra vs Clue
- Tebra vs Dentrix
- Tebra vs DHIS2
- Tebra vs Athenahealth
- Tebra vs Epic Systems
- Tebra vs Cerner
- Tebra vs Amwell
- Tebra vs ChiroTouch
- Tebra vs RXNT
- Tebra vs Updox
- Tebra vs Kareo
- Tebra vs Healthie
- Tebra vs Allscripts Professional EHR
- Tebra vs Bahmni
- Tebra vs Beckman Coulter DxONE
- Tebra vs Carestream Dental
- Tebra vs athenaOne
- Tebra vs Kareo Clinical
- Tebra vs Allscripts TouchWorks
